Source:http://linkedlifedata.com/resource/pubmed/id/16374397
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
22 Pt 1
|
pubmed:dateCreated |
2005-12-23
|
pubmed:abstractText |
Psoriasis is a common dermatosis that affects 3-5% of the European population. Current treatments offer considerable clinical benefits, but their use is limited due to tolerance problems. Recent years have seen the development of new treatments, used separately or in combination to improve the chronic lesions caused by this disease. T cells play an important role in the pathogenesis of psoriasis. Various techniques target the T cells and the immunological mechanisms involved in their activation. In 2005, treatment of psoriasis is directed essentially towards immunological pathways.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0755-4982
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
17
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1727-36
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
2005
|
pubmed:articleTitle |
[Mechanisms and treatment of psoriasis].
|
pubmed:affiliation |
Service central de la pharmacie et du médicament, Laboratoire de contrôle de la qualité, Hôpital de la Conception, Marseille (13). joellejoachim@hotmail.com
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|